NRC Health price to book ratio NRC

Market value divided by the book value of the company's net assets, since 2013.

Today, Oct 23, 2026: 74.1×
10-year median: 15.5×
Against its 10-year history: 100th; percentile: 0 is its lowest day, 100 its highest
10-year range: 4.6× to 74.9×
Peer median: 3.0×

NRC Health's price to book ratio is 74.1× as of Oct 23, 2026.

That is above its ten-year median of 15.5×, higher than on 100% of days in the last ten years.

Over that time it ranged from 4.6× in Nov 2016 to 74.9× in Aug 2026.

The median for 3 diagnostics and research stocks of a similar size is 3.0×.

Price to book ratio over time

median 15.5×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	74.1×	19.1×	74.9×
2025	29.5×	7.7×	29.6×
2024	11.8×	10.7×	20.1×
2023	16.8×	13.2×	17.7×
2022	13.6×	10.1×	14.9×
2021	12.7×	12.6×	23.0×
2020	19.1×	19.1×	59.5×
2019	57.3×	31.3×	71.4×
2018	31.8×	7.9×	36.9×
2017	10.3×	5.2×	10.6×
2016	5.7×	3.8×	5.7×
2015	4.5×	3.3×	4.7×
2014	4.0×	3.7×	6.5×
2013	6.5×	1.6×	7.1×

Against its peers

Companies in Medical - Diagnostics & Research nearest NRC Health's size, closest first, today.

Company	Price to book ratio
NRCNRC Health	74.1×
ICCCImmucell	3.0×
CDNACareDx	8.4×
VCYTVeracyte	2.8×
Peer median	3.0×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on NRC Health

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.